The ''CORE-64'' Study.
Completed
- Conditions
- Multicenter, clinical study.
- Registration Number
- NL-OMON21519
- Lead Sponsor
- Toshiba Medical Systems Corporation
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
1. Male or female patients;
2. age 40 years or greater;
Exclusion Criteria
1. Known allergy to iodinated contrast media;
2. history of contrast-induced nephropathy;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of MDCTA for identifying coronary artery stenosis ¡Ý 50% in a patient with suspected coronary artery disease, compared with conventional coronary angiography.
- Secondary Outcome Measures
Name Time Method